-
Most Popular
Options Trading
My No. 1 Long-Term Biotech Pick
Gilead Sciences (GILD) is in a clearly defined bull channel with support at its 50-day moving average.
Big Tech Won’t Hold up the Market
Yesterday's parade of news about Syria, Larry Summers and the debt limit wasn't kind to QQQ's biggest holdings.
10 Must-See Charts in the Retail Sector
The retail sector is looking shaky -- with the charts of some key stocks in dangerous territory -- but three retailers have the potential for a breakout.
Traders Should Move Quickly on 3D Systems
3D Systems (DDD) broke from a compound top on high volume.
It’s Time to Cash In on This Huge Biotech Winner
NPS Pharmaceuticals (NPSP) has risen 159% since my initial recommendation.
Stocks Are Nearing Bounce Territory
Correction achieved -- the S&P 500 and Dow Jones have taken a pretty hard tumble in the past few days. But important support is nearing.
This Miner’s Stock Will Keep Digging the Hole Deeper
Freeport-McMoRan Copper & Gold (FCX) is on the verge of issuing a sell signal after its latest failed rally attempt.
Exxon Mobil: Oversold, But Still Wobbly
Exxon Mobil (XOM) has receded quite sharply over the past three weeks, but the shorts still might have additional opportunity in the coming days.